Fifty-five basal cell carcinomas treated with topical imiquimod:: Outcome at 5-year follow-up

被引：47

作者：

Vidal, David ^{[1
]}

Matias-Guiu, Xavier ^{[1
]}

Alomar, Agustin ^{[1
]}

机构：

[1] Hosp Dos Maig, Dept Dermatol, Barcelona 08025, Spain

来源：

ARCHIVES OF DERMATOLOGY | 2007年 / 143卷 / 02期

关键词：

D O I：

10.1001/archderm.143.2.266

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 [皮肤病与性病学];

摘要：

引用

收藏

页码：266 / 268

页数：3

相关论文

共 10 条

[1]

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream [J].

Beutner, KR ;

Geisse, JK ;

Helman, D ;

Fox, TL ;

Ginkel, A ;

Owens, ML .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (06) :1002-1007

[2]

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies [J].

Geisse, J ;

Caro, I ;

Lindholm, J ;

Golitz, L ;

Stampone, P ;

Owens, M .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (05) :722-733

[3]

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study [J].

Geisse, JK ;

Rich, P ;

Pandya, A ;

Gross, K ;

Andres, K ;

Ginkel, A ;

Owens, M .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (03) :390-398

[4]

Gollnick H, 2005, EUR J DERMATOL, V15, P374

[5]

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial [J].

Marks, R ;

Gebauer, K ;

Shumack, S ;

Amies, M ;

Bryden, J ;

Fox, TL ;

Owens, ML .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (05) :807-813

[6]

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma:: results from a randomized vehicle-controlled phase III study in Europe [J].

Schulze, HJ ;

Cribier, B ;

Requena, L ;

Reifenberger, J ;

Ferrándiz, C ;

Diez, AG ;

Tebbs, V ;

McRae, S .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (05) :939-947

[7]

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma - Comparison of dosing regimens [J].

Shumack, S ;

Robinson, J ;

Kossard, S ;

Golitz, L ;

Greenway, H ;

Schroeter, A ;

Andres, K ;

Amies, M ;

Owens, M .

ARCHIVES OF DERMATOLOGY, 2002, 138 (09) :1165-1171

[8]

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion [J].

Sterry, W ;

Ruzicka, T ;

Herrera, E ;

Takwale, A ;

Bichel, J ;

Andres, K ;

Ding, L ;

Thissen, MRTM .

BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (06) :1227-1236

[9]

Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma [J].

Vidal, D ;

Matías-Guiu, X ;

Alomar, A .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (05) :518-525

[10]

WEEDON D, 1997, SKIN PATHOLOGY, P647